nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Ticagrelor—coronary artery disease	0.0432	0.0698	CbGbCtD
Fesoterodine—ABCB1—Clopidogrel—coronary artery disease	0.0267	0.0431	CbGbCtD
Fesoterodine—ABCB1—Perindopril—coronary artery disease	0.0267	0.0431	CbGbCtD
Fesoterodine—CYP3A4—Ticagrelor—coronary artery disease	0.0259	0.0418	CbGbCtD
Fesoterodine—ABCB1—Telmisartan—coronary artery disease	0.0233	0.0377	CbGbCtD
Fesoterodine—ABCB1—Pitavastatin—coronary artery disease	0.0233	0.0377	CbGbCtD
Fesoterodine—CYP3A4—Fenofibrate—coronary artery disease	0.023	0.0373	CbGbCtD
Fesoterodine—ABCB1—Enalapril—coronary artery disease	0.0221	0.0357	CbGbCtD
Fesoterodine—ABCB1—Lisinopril—coronary artery disease	0.0221	0.0357	CbGbCtD
Fesoterodine—CYP2D6—Niacin—coronary artery disease	0.019	0.0308	CbGbCtD
Fesoterodine—ABCB1—Timolol—coronary artery disease	0.0188	0.0304	CbGbCtD
Fesoterodine—CYP3A4—Gemfibrozil—coronary artery disease	0.0184	0.0298	CbGbCtD
Fesoterodine—CYP2D6—Timolol—coronary artery disease	0.0177	0.0286	CbGbCtD
Fesoterodine—ABCB1—Ezetimibe—coronary artery disease	0.0172	0.0278	CbGbCtD
Fesoterodine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0167	0.0271	CbGbCtD
Fesoterodine—ABCB1—Captopril—coronary artery disease	0.0165	0.0268	CbGbCtD
Fesoterodine—CYP3A4—Clopidogrel—coronary artery disease	0.016	0.0258	CbGbCtD
Fesoterodine—ABCB1—Simvastatin—coronary artery disease	0.016	0.0258	CbGbCtD
Fesoterodine—ABCB1—Pravastatin—coronary artery disease	0.0156	0.0253	CbGbCtD
Fesoterodine—ABCB1—Lovastatin—coronary artery disease	0.0156	0.0253	CbGbCtD
Fesoterodine—CYP2D6—Captopril—coronary artery disease	0.0156	0.0252	CbGbCtD
Fesoterodine—CYP2D6—Simvastatin—coronary artery disease	0.0151	0.0244	CbGbCtD
Fesoterodine—CYP3A4—Eplerenone—coronary artery disease	0.0149	0.024	CbGbCtD
Fesoterodine—CYP2D6—Pravastatin—coronary artery disease	0.0147	0.0238	CbGbCtD
Fesoterodine—CYP2D6—Lovastatin—coronary artery disease	0.0147	0.0238	CbGbCtD
Fesoterodine—ABCB1—Atorvastatin—coronary artery disease	0.0142	0.023	CbGbCtD
Fesoterodine—CYP2D6—Atorvastatin—coronary artery disease	0.0134	0.0217	CbGbCtD
Fesoterodine—CYP3A4—Enalapril—coronary artery disease	0.0132	0.0214	CbGbCtD
Fesoterodine—ABCB1—Losartan—coronary artery disease	0.013	0.0211	CbGbCtD
Fesoterodine—CYP3A4—Ezetimibe—coronary artery disease	0.0103	0.0167	CbGbCtD
Fesoterodine—CYP3A4—Rosuvastatin—coronary artery disease	0.0103	0.0167	CbGbCtD
Fesoterodine—CYP3A4—Simvastatin—coronary artery disease	0.00957	0.0155	CbGbCtD
Fesoterodine—CYP3A4—Lovastatin—coronary artery disease	0.00937	0.0152	CbGbCtD
Fesoterodine—CYP3A4—Pravastatin—coronary artery disease	0.00937	0.0152	CbGbCtD
Fesoterodine—CYP3A4—Atorvastatin—coronary artery disease	0.00853	0.0138	CbGbCtD
Fesoterodine—CYP3A4—Losartan—coronary artery disease	0.0078	0.0126	CbGbCtD
Fesoterodine—Feeling abnormal—Telmisartan—coronary artery disease	0.000158	0.000628	CcSEcCtD
Fesoterodine—Palpitations—Ramipril—coronary artery disease	0.000158	0.000627	CcSEcCtD
Fesoterodine—Pruritus—Simvastatin—coronary artery disease	0.000157	0.000625	CcSEcCtD
Fesoterodine—Dizziness—Lovastatin—coronary artery disease	0.000157	0.000625	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000157	0.000623	CcSEcCtD
Fesoterodine—Vertigo—Timolol—coronary artery disease	0.000157	0.000623	CcSEcCtD
Fesoterodine—Back pain—Lisinopril—coronary artery disease	0.000156	0.000622	CcSEcCtD
Fesoterodine—Somnolence—Furosemide—coronary artery disease	0.000156	0.000622	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000156	0.000621	CcSEcCtD
Fesoterodine—Diarrhoea—Eplerenone—coronary artery disease	0.000156	0.000621	CcSEcCtD
Fesoterodine—Fatigue—Perindopril—coronary artery disease	0.000156	0.00062	CcSEcCtD
Fesoterodine—Cough—Ramipril—coronary artery disease	0.000156	0.000619	CcSEcCtD
Fesoterodine—Urticaria—Trandolapril—coronary artery disease	0.000155	0.000616	CcSEcCtD
Fesoterodine—Constipation—Perindopril—coronary artery disease	0.000155	0.000615	CcSEcCtD
Fesoterodine—Hypersensitivity—Valsartan—coronary artery disease	0.000155	0.000615	CcSEcCtD
Fesoterodine—Urticaria—Enalapril—coronary artery disease	0.000154	0.000614	CcSEcCtD
Fesoterodine—Abdominal pain—Trandolapril—coronary artery disease	0.000154	0.000613	CcSEcCtD
Fesoterodine—Dizziness—Ezetimibe—coronary artery disease	0.000154	0.000613	CcSEcCtD
Fesoterodine—Palpitations—Timolol—coronary artery disease	0.000154	0.000613	CcSEcCtD
Fesoterodine—Abdominal pain—Enalapril—coronary artery disease	0.000154	0.000611	CcSEcCtD
Fesoterodine—Feeling abnormal—Captopril—coronary artery disease	0.000154	0.000611	CcSEcCtD
Fesoterodine—Insomnia—Losartan—coronary artery disease	0.000154	0.00061	CcSEcCtD
Fesoterodine—Rash—Fenofibrate—coronary artery disease	0.000153	0.00061	CcSEcCtD
Fesoterodine—Dermatitis—Fenofibrate—coronary artery disease	0.000153	0.000609	CcSEcCtD
Fesoterodine—Headache—Fenofibrate—coronary artery disease	0.000152	0.000606	CcSEcCtD
Fesoterodine—Vision blurred—Lisinopril—coronary artery disease	0.000152	0.000606	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Captopril—coronary artery disease	0.000152	0.000606	CcSEcCtD
Fesoterodine—Urticaria—Telmisartan—coronary artery disease	0.000152	0.000605	CcSEcCtD
Fesoterodine—Cough—Timolol—coronary artery disease	0.000152	0.000605	CcSEcCtD
Fesoterodine—Diarrhoea—Simvastatin—coronary artery disease	0.000152	0.000605	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000152	0.000604	CcSEcCtD
Fesoterodine—Chest pain—Ramipril—coronary artery disease	0.000152	0.000604	CcSEcCtD
Fesoterodine—Fatigue—Furosemide—coronary artery disease	0.000152	0.000603	CcSEcCtD
Fesoterodine—Abdominal pain—Telmisartan—coronary artery disease	0.000152	0.000603	CcSEcCtD
Fesoterodine—Somnolence—Losartan—coronary artery disease	0.000151	0.0006	CcSEcCtD
Fesoterodine—Dizziness—Eplerenone—coronary artery disease	0.000151	0.0006	CcSEcCtD
Fesoterodine—Rash—Clopidogrel—coronary artery disease	0.000151	0.0006	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000151	0.0006	CcSEcCtD
Fesoterodine—Dermatitis—Clopidogrel—coronary artery disease	0.000151	0.000599	CcSEcCtD
Fesoterodine—Asthenia—Valsartan—coronary artery disease	0.000151	0.000599	CcSEcCtD
Fesoterodine—Constipation—Furosemide—coronary artery disease	0.00015	0.000598	CcSEcCtD
Fesoterodine—Hypersensitivity—Niacin—coronary artery disease	0.00015	0.000598	CcSEcCtD
Fesoterodine—Asthenia—Olmesartan—coronary artery disease	0.00015	0.000596	CcSEcCtD
Fesoterodine—Headache—Clopidogrel—coronary artery disease	0.00015	0.000596	CcSEcCtD
Fesoterodine—Rash—Lovastatin—coronary artery disease	0.00015	0.000596	CcSEcCtD
Fesoterodine—Dermatitis—Lovastatin—coronary artery disease	0.00015	0.000595	CcSEcCtD
Fesoterodine—Dyspepsia—Losartan—coronary artery disease	0.000149	0.000594	CcSEcCtD
Fesoterodine—Feeling abnormal—Perindopril—coronary artery disease	0.000149	0.000593	CcSEcCtD
Fesoterodine—Headache—Lovastatin—coronary artery disease	0.000149	0.000592	CcSEcCtD
Fesoterodine—Pruritus—Valsartan—coronary artery disease	0.000149	0.00059	CcSEcCtD
Fesoterodine—Dry mouth—Ramipril—coronary artery disease	0.000149	0.00059	CcSEcCtD
Fesoterodine—Chest pain—Timolol—coronary artery disease	0.000148	0.00059	CcSEcCtD
Fesoterodine—Hypersensitivity—Pravastatin—coronary artery disease	0.000148	0.000589	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000148	0.000588	CcSEcCtD
Fesoterodine—Angioedema—Lisinopril—coronary artery disease	0.000148	0.000588	CcSEcCtD
Fesoterodine—Pruritus—Olmesartan—coronary artery disease	0.000148	0.000588	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000147	0.000586	CcSEcCtD
Fesoterodine—Abdominal pain—Captopril—coronary artery disease	0.000147	0.000586	CcSEcCtD
Fesoterodine—Dizziness—Simvastatin—coronary artery disease	0.000147	0.000584	CcSEcCtD
Fesoterodine—Rash—Ezetimibe—coronary artery disease	0.000147	0.000584	CcSEcCtD
Fesoterodine—Dermatitis—Ezetimibe—coronary artery disease	0.000147	0.000584	CcSEcCtD
Fesoterodine—Confusional state—Ramipril—coronary artery disease	0.000147	0.000584	CcSEcCtD
Fesoterodine—Asthenia—Niacin—coronary artery disease	0.000146	0.000582	CcSEcCtD
Fesoterodine—Fatigue—Losartan—coronary artery disease	0.000146	0.000582	CcSEcCtD
Fesoterodine—Headache—Ezetimibe—coronary artery disease	0.000146	0.000581	CcSEcCtD
Fesoterodine—Vertigo—Lisinopril—coronary artery disease	0.000145	0.000578	CcSEcCtD
Fesoterodine—Dry mouth—Timolol—coronary artery disease	0.000145	0.000577	CcSEcCtD
Fesoterodine—Constipation—Losartan—coronary artery disease	0.000145	0.000577	CcSEcCtD
Fesoterodine—Feeling abnormal—Furosemide—coronary artery disease	0.000145	0.000576	CcSEcCtD
Fesoterodine—Nausea—Fenofibrate—coronary artery disease	0.000145	0.000575	CcSEcCtD
Fesoterodine—Pruritus—Niacin—coronary artery disease	0.000144	0.000574	CcSEcCtD
Fesoterodine—Asthenia—Pravastatin—coronary artery disease	0.000144	0.000573	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000144	0.000572	CcSEcCtD
Fesoterodine—Rash—Eplerenone—coronary artery disease	0.000144	0.000572	CcSEcCtD
Fesoterodine—Urticaria—Perindopril—coronary artery disease	0.000144	0.000572	CcSEcCtD
Fesoterodine—Hypersensitivity—Trandolapril—coronary artery disease	0.000144	0.000572	CcSEcCtD
Fesoterodine—Dermatitis—Eplerenone—coronary artery disease	0.000144	0.000571	CcSEcCtD
Fesoterodine—Diarrhoea—Valsartan—coronary artery disease	0.000144	0.000571	CcSEcCtD
Fesoterodine—Confusional state—Timolol—coronary artery disease	0.000144	0.00057	CcSEcCtD
Fesoterodine—Hypersensitivity—Enalapril—coronary artery disease	0.000143	0.000569	CcSEcCtD
Fesoterodine—Abdominal pain—Perindopril—coronary artery disease	0.000143	0.000569	CcSEcCtD
Fesoterodine—Palpitations—Lisinopril—coronary artery disease	0.000143	0.000568	CcSEcCtD
Fesoterodine—Diarrhoea—Olmesartan—coronary artery disease	0.000143	0.000568	CcSEcCtD
Fesoterodine—Headache—Eplerenone—coronary artery disease	0.000143	0.000568	CcSEcCtD
Fesoterodine—Nervous system disorder—Ramipril—coronary artery disease	0.000143	0.000568	CcSEcCtD
Fesoterodine—Pruritus—Pravastatin—coronary artery disease	0.000142	0.000565	CcSEcCtD
Fesoterodine—Nausea—Clopidogrel—coronary artery disease	0.000142	0.000565	CcSEcCtD
Fesoterodine—Tachycardia—Ramipril—coronary artery disease	0.000142	0.000565	CcSEcCtD
Fesoterodine—Skin disorder—Ramipril—coronary artery disease	0.000141	0.000562	CcSEcCtD
Fesoterodine—Infection—Timolol—coronary artery disease	0.000141	0.000562	CcSEcCtD
Fesoterodine—Hypersensitivity—Telmisartan—coronary artery disease	0.000141	0.000562	CcSEcCtD
Fesoterodine—Cough—Lisinopril—coronary artery disease	0.000141	0.000561	CcSEcCtD
Fesoterodine—Nausea—Lovastatin—coronary artery disease	0.000141	0.000561	CcSEcCtD
Fesoterodine—Rash—Simvastatin—coronary artery disease	0.00014	0.000557	CcSEcCtD
Fesoterodine—Dermatitis—Simvastatin—coronary artery disease	0.00014	0.000557	CcSEcCtD
Fesoterodine—Asthenia—Trandolapril—coronary artery disease	0.00014	0.000557	CcSEcCtD
Fesoterodine—Feeling abnormal—Losartan—coronary artery disease	0.00014	0.000556	CcSEcCtD
Fesoterodine—Urticaria—Furosemide—coronary artery disease	0.00014	0.000556	CcSEcCtD
Fesoterodine—Diarrhoea—Niacin—coronary artery disease	0.00014	0.000555	CcSEcCtD
Fesoterodine—Nervous system disorder—Timolol—coronary artery disease	0.00014	0.000555	CcSEcCtD
Fesoterodine—Asthenia—Enalapril—coronary artery disease	0.000139	0.000554	CcSEcCtD
Fesoterodine—Headache—Simvastatin—coronary artery disease	0.000139	0.000554	CcSEcCtD
Fesoterodine—Abdominal pain—Furosemide—coronary artery disease	0.000139	0.000553	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Losartan—coronary artery disease	0.000139	0.000552	CcSEcCtD
Fesoterodine—Dizziness—Valsartan—coronary artery disease	0.000139	0.000552	CcSEcCtD
Fesoterodine—Nausea—Ezetimibe—coronary artery disease	0.000138	0.00055	CcSEcCtD
Fesoterodine—Skin disorder—Timolol—coronary artery disease	0.000138	0.00055	CcSEcCtD
Fesoterodine—Dizziness—Olmesartan—coronary artery disease	0.000138	0.000549	CcSEcCtD
Fesoterodine—Pruritus—Trandolapril—coronary artery disease	0.000138	0.000549	CcSEcCtD
Fesoterodine—Chest pain—Lisinopril—coronary artery disease	0.000138	0.000548	CcSEcCtD
Fesoterodine—Asthenia—Telmisartan—coronary artery disease	0.000138	0.000547	CcSEcCtD
Fesoterodine—Pruritus—Enalapril—coronary artery disease	0.000138	0.000547	CcSEcCtD
Fesoterodine—Diarrhoea—Pravastatin—coronary artery disease	0.000138	0.000547	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000137	0.000544	CcSEcCtD
Fesoterodine—Pruritus—Telmisartan—coronary artery disease	0.000136	0.000539	CcSEcCtD
Fesoterodine—Nausea—Eplerenone—coronary artery disease	0.000136	0.000539	CcSEcCtD
Fesoterodine—Dizziness—Niacin—coronary artery disease	0.000135	0.000537	CcSEcCtD
Fesoterodine—Urticaria—Losartan—coronary artery disease	0.000135	0.000536	CcSEcCtD
Fesoterodine—Dry mouth—Lisinopril—coronary artery disease	0.000135	0.000535	CcSEcCtD
Fesoterodine—Abdominal pain—Losartan—coronary artery disease	0.000134	0.000534	CcSEcCtD
Fesoterodine—Asthenia—Captopril—coronary artery disease	0.000134	0.000532	CcSEcCtD
Fesoterodine—Diarrhoea—Trandolapril—coronary artery disease	0.000134	0.000531	CcSEcCtD
Fesoterodine—Confusional state—Lisinopril—coronary artery disease	0.000133	0.000529	CcSEcCtD
Fesoterodine—Diarrhoea—Enalapril—coronary artery disease	0.000133	0.000529	CcSEcCtD
Fesoterodine—Dizziness—Pravastatin—coronary artery disease	0.000133	0.000528	CcSEcCtD
Fesoterodine—Rash—Valsartan—coronary artery disease	0.000132	0.000526	CcSEcCtD
Fesoterodine—Dermatitis—Valsartan—coronary artery disease	0.000132	0.000526	CcSEcCtD
Fesoterodine—Nausea—Simvastatin—coronary artery disease	0.000132	0.000525	CcSEcCtD
Fesoterodine—Pruritus—Captopril—coronary artery disease	0.000132	0.000524	CcSEcCtD
Fesoterodine—Rash—Olmesartan—coronary artery disease	0.000132	0.000524	CcSEcCtD
Fesoterodine—Insomnia—Ramipril—coronary artery disease	0.000132	0.000523	CcSEcCtD
Fesoterodine—Dermatitis—Olmesartan—coronary artery disease	0.000132	0.000523	CcSEcCtD
Fesoterodine—Headache—Valsartan—coronary artery disease	0.000132	0.000523	CcSEcCtD
Fesoterodine—Diarrhoea—Telmisartan—coronary artery disease	0.000131	0.000521	CcSEcCtD
Fesoterodine—Infection—Lisinopril—coronary artery disease	0.000131	0.000521	CcSEcCtD
Fesoterodine—Headache—Olmesartan—coronary artery disease	0.000131	0.00052	CcSEcCtD
Fesoterodine—Asthenia—Perindopril—coronary artery disease	0.00013	0.000516	CcSEcCtD
Fesoterodine—Hypersensitivity—Furosemide—coronary artery disease	0.00013	0.000515	CcSEcCtD
Fesoterodine—Somnolence—Ramipril—coronary artery disease	0.000129	0.000514	CcSEcCtD
Fesoterodine—Dizziness—Trandolapril—coronary artery disease	0.000129	0.000513	CcSEcCtD
Fesoterodine—Tachycardia—Lisinopril—coronary artery disease	0.000129	0.000512	CcSEcCtD
Fesoterodine—Insomnia—Timolol—coronary artery disease	0.000129	0.000512	CcSEcCtD
Fesoterodine—Rash—Niacin—coronary artery disease	0.000129	0.000512	CcSEcCtD
Fesoterodine—Dermatitis—Niacin—coronary artery disease	0.000129	0.000511	CcSEcCtD
Fesoterodine—Dizziness—Enalapril—coronary artery disease	0.000129	0.000511	CcSEcCtD
Fesoterodine—Skin disorder—Lisinopril—coronary artery disease	0.000128	0.00051	CcSEcCtD
Fesoterodine—Dyspepsia—Ramipril—coronary artery disease	0.000128	0.000509	CcSEcCtD
Fesoterodine—Pruritus—Perindopril—coronary artery disease	0.000128	0.000509	CcSEcCtD
Fesoterodine—Headache—Niacin—coronary artery disease	0.000128	0.000508	CcSEcCtD
Fesoterodine—Diarrhoea—Captopril—coronary artery disease	0.000128	0.000507	CcSEcCtD
Fesoterodine—Dizziness—Telmisartan—coronary artery disease	0.000127	0.000504	CcSEcCtD
Fesoterodine—Rash—Pravastatin—coronary artery disease	0.000127	0.000504	CcSEcCtD
Fesoterodine—Dermatitis—Pravastatin—coronary artery disease	0.000127	0.000503	CcSEcCtD
Fesoterodine—Somnolence—Timolol—coronary artery disease	0.000127	0.000503	CcSEcCtD
Fesoterodine—Asthenia—Furosemide—coronary artery disease	0.000126	0.000502	CcSEcCtD
Fesoterodine—Headache—Pravastatin—coronary artery disease	0.000126	0.000501	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000126	0.0005	CcSEcCtD
Fesoterodine—Fatigue—Ramipril—coronary artery disease	0.000126	0.000499	CcSEcCtD
Fesoterodine—Dyspepsia—Timolol—coronary artery disease	0.000125	0.000498	CcSEcCtD
Fesoterodine—Hypersensitivity—Losartan—coronary artery disease	0.000125	0.000497	CcSEcCtD
Fesoterodine—Nausea—Valsartan—coronary artery disease	0.000125	0.000496	CcSEcCtD
Fesoterodine—Pruritus—Furosemide—coronary artery disease	0.000125	0.000495	CcSEcCtD
Fesoterodine—Constipation—Ramipril—coronary artery disease	0.000125	0.000495	CcSEcCtD
Fesoterodine—Nausea—Olmesartan—coronary artery disease	0.000124	0.000493	CcSEcCtD
Fesoterodine—Diarrhoea—Perindopril—coronary artery disease	0.000124	0.000492	CcSEcCtD
Fesoterodine—Dizziness—Captopril—coronary artery disease	0.000123	0.00049	CcSEcCtD
Fesoterodine—Rash—Trandolapril—coronary artery disease	0.000123	0.000489	CcSEcCtD
Fesoterodine—Dermatitis—Trandolapril—coronary artery disease	0.000123	0.000489	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000123	0.000488	CcSEcCtD
Fesoterodine—Fatigue—Timolol—coronary artery disease	0.000123	0.000488	CcSEcCtD
Fesoterodine—Rash—Enalapril—coronary artery disease	0.000123	0.000487	CcSEcCtD
Fesoterodine—Dermatitis—Enalapril—coronary artery disease	0.000122	0.000487	CcSEcCtD
Fesoterodine—Headache—Trandolapril—coronary artery disease	0.000122	0.000486	CcSEcCtD
Fesoterodine—Asthenia—Losartan—coronary artery disease	0.000122	0.000484	CcSEcCtD
Fesoterodine—Headache—Enalapril—coronary artery disease	0.000122	0.000484	CcSEcCtD
Fesoterodine—Nausea—Niacin—coronary artery disease	0.000121	0.000482	CcSEcCtD
Fesoterodine—Rash—Telmisartan—coronary artery disease	0.000121	0.000481	CcSEcCtD
Fesoterodine—Dermatitis—Telmisartan—coronary artery disease	0.000121	0.00048	CcSEcCtD
Fesoterodine—Diarrhoea—Furosemide—coronary artery disease	0.00012	0.000479	CcSEcCtD
Fesoterodine—Pruritus—Losartan—coronary artery disease	0.00012	0.000478	CcSEcCtD
Fesoterodine—Headache—Telmisartan—coronary artery disease	0.00012	0.000477	CcSEcCtD
Fesoterodine—Feeling abnormal—Ramipril—coronary artery disease	0.00012	0.000477	CcSEcCtD
Fesoterodine—Dizziness—Perindopril—coronary artery disease	0.00012	0.000476	CcSEcCtD
Fesoterodine—Insomnia—Lisinopril—coronary artery disease	0.000119	0.000475	CcSEcCtD
Fesoterodine—Nausea—Pravastatin—coronary artery disease	0.000119	0.000475	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000119	0.000473	CcSEcCtD
Fesoterodine—Rash—Captopril—coronary artery disease	0.000118	0.000467	CcSEcCtD
Fesoterodine—Dermatitis—Captopril—coronary artery disease	0.000117	0.000467	CcSEcCtD
Fesoterodine—Somnolence—Lisinopril—coronary artery disease	0.000117	0.000467	CcSEcCtD
Fesoterodine—Feeling abnormal—Timolol—coronary artery disease	0.000117	0.000466	CcSEcCtD
Fesoterodine—Headache—Captopril—coronary artery disease	0.000117	0.000464	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Timolol—coronary artery disease	0.000116	0.000463	CcSEcCtD
Fesoterodine—Dizziness—Furosemide—coronary artery disease	0.000116	0.000463	CcSEcCtD
Fesoterodine—Dyspepsia—Lisinopril—coronary artery disease	0.000116	0.000462	CcSEcCtD
Fesoterodine—Diarrhoea—Losartan—coronary artery disease	0.000116	0.000462	CcSEcCtD
Fesoterodine—Nausea—Trandolapril—coronary artery disease	0.000116	0.000461	CcSEcCtD
Fesoterodine—Urticaria—Ramipril—coronary artery disease	0.000116	0.00046	CcSEcCtD
Fesoterodine—Nausea—Enalapril—coronary artery disease	0.000115	0.000459	CcSEcCtD
Fesoterodine—Abdominal pain—Ramipril—coronary artery disease	0.000115	0.000458	CcSEcCtD
Fesoterodine—Rash—Perindopril—coronary artery disease	0.000114	0.000454	CcSEcCtD
Fesoterodine—Dermatitis—Perindopril—coronary artery disease	0.000114	0.000453	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000114	0.000453	CcSEcCtD
Fesoterodine—Nausea—Telmisartan—coronary artery disease	0.000114	0.000453	CcSEcCtD
Fesoterodine—Fatigue—Lisinopril—coronary artery disease	0.000114	0.000453	CcSEcCtD
Fesoterodine—Headache—Perindopril—coronary artery disease	0.000113	0.000451	CcSEcCtD
Fesoterodine—Urticaria—Timolol—coronary artery disease	0.000113	0.000449	CcSEcCtD
Fesoterodine—Constipation—Lisinopril—coronary artery disease	0.000113	0.000449	CcSEcCtD
Fesoterodine—Abdominal pain—Timolol—coronary artery disease	0.000113	0.000447	CcSEcCtD
Fesoterodine—Dizziness—Losartan—coronary artery disease	0.000112	0.000446	CcSEcCtD
Fesoterodine—Rash—Furosemide—coronary artery disease	0.000111	0.000441	CcSEcCtD
Fesoterodine—Dermatitis—Furosemide—coronary artery disease	0.000111	0.000441	CcSEcCtD
Fesoterodine—Nausea—Captopril—coronary artery disease	0.000111	0.00044	CcSEcCtD
Fesoterodine—Headache—Furosemide—coronary artery disease	0.00011	0.000438	CcSEcCtD
Fesoterodine—Feeling abnormal—Lisinopril—coronary artery disease	0.000109	0.000433	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000108	0.000429	CcSEcCtD
Fesoterodine—Nausea—Perindopril—coronary artery disease	0.000108	0.000427	CcSEcCtD
Fesoterodine—Hypersensitivity—Ramipril—coronary artery disease	0.000107	0.000426	CcSEcCtD
Fesoterodine—Rash—Losartan—coronary artery disease	0.000107	0.000426	CcSEcCtD
Fesoterodine—Dermatitis—Losartan—coronary artery disease	0.000107	0.000425	CcSEcCtD
Fesoterodine—Headache—Losartan—coronary artery disease	0.000106	0.000423	CcSEcCtD
Fesoterodine—Urticaria—Lisinopril—coronary artery disease	0.000105	0.000417	CcSEcCtD
Fesoterodine—Hypersensitivity—Timolol—coronary artery disease	0.000105	0.000417	CcSEcCtD
Fesoterodine—Nausea—Furosemide—coronary artery disease	0.000105	0.000416	CcSEcCtD
Fesoterodine—Asthenia—Ramipril—coronary artery disease	0.000104	0.000415	CcSEcCtD
Fesoterodine—Abdominal pain—Lisinopril—coronary artery disease	0.000104	0.000415	CcSEcCtD
Fesoterodine—Pruritus—Ramipril—coronary artery disease	0.000103	0.000409	CcSEcCtD
Fesoterodine—Asthenia—Timolol—coronary artery disease	0.000102	0.000406	CcSEcCtD
Fesoterodine—Nausea—Losartan—coronary artery disease	0.000101	0.000401	CcSEcCtD
Fesoterodine—Pruritus—Timolol—coronary artery disease	0.000101	0.0004	CcSEcCtD
Fesoterodine—Diarrhoea—Ramipril—coronary artery disease	9.96e-05	0.000396	CcSEcCtD
Fesoterodine—Diarrhoea—Timolol—coronary artery disease	9.74e-05	0.000387	CcSEcCtD
Fesoterodine—Hypersensitivity—Lisinopril—coronary artery disease	9.73e-05	0.000387	CcSEcCtD
Fesoterodine—Dizziness—Ramipril—coronary artery disease	9.63e-05	0.000383	CcSEcCtD
Fesoterodine—Asthenia—Lisinopril—coronary artery disease	9.47e-05	0.000377	CcSEcCtD
Fesoterodine—Dizziness—Timolol—coronary artery disease	9.41e-05	0.000374	CcSEcCtD
Fesoterodine—Pruritus—Lisinopril—coronary artery disease	9.34e-05	0.000371	CcSEcCtD
Fesoterodine—Rash—Ramipril—coronary artery disease	9.18e-05	0.000365	CcSEcCtD
Fesoterodine—Dermatitis—Ramipril—coronary artery disease	9.17e-05	0.000365	CcSEcCtD
Fesoterodine—Headache—Ramipril—coronary artery disease	9.12e-05	0.000363	CcSEcCtD
Fesoterodine—Diarrhoea—Lisinopril—coronary artery disease	9.03e-05	0.000359	CcSEcCtD
Fesoterodine—Rash—Timolol—coronary artery disease	8.97e-05	0.000357	CcSEcCtD
Fesoterodine—Dermatitis—Timolol—coronary artery disease	8.97e-05	0.000356	CcSEcCtD
Fesoterodine—Headache—Timolol—coronary artery disease	8.92e-05	0.000354	CcSEcCtD
Fesoterodine—Dizziness—Lisinopril—coronary artery disease	8.73e-05	0.000347	CcSEcCtD
Fesoterodine—Nausea—Ramipril—coronary artery disease	8.65e-05	0.000344	CcSEcCtD
Fesoterodine—Nausea—Timolol—coronary artery disease	8.45e-05	0.000336	CcSEcCtD
Fesoterodine—Rash—Lisinopril—coronary artery disease	8.33e-05	0.000331	CcSEcCtD
Fesoterodine—Dermatitis—Lisinopril—coronary artery disease	8.32e-05	0.000331	CcSEcCtD
Fesoterodine—Headache—Lisinopril—coronary artery disease	8.27e-05	0.000329	CcSEcCtD
Fesoterodine—Nausea—Lisinopril—coronary artery disease	7.84e-05	0.000312	CcSEcCtD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	5.77e-06	4.42e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—C3—coronary artery disease	5.76e-06	4.42e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	5.75e-06	4.41e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—C3—coronary artery disease	5.74e-06	4.4e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—coronary artery disease	5.7e-06	4.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	5.69e-06	4.37e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—C3—coronary artery disease	5.68e-06	4.36e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.67e-06	4.35e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PIK3CA—coronary artery disease	5.67e-06	4.35e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GOT1—coronary artery disease	5.63e-06	4.32e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GGT1—coronary artery disease	5.63e-06	4.32e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—coronary artery disease	5.57e-06	4.27e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—JAK2—coronary artery disease	5.54e-06	4.25e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	5.49e-06	4.21e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—coronary artery disease	5.49e-06	4.21e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	5.47e-06	4.2e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AGT—coronary artery disease	5.47e-06	4.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AGT—coronary artery disease	5.45e-06	4.18e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	5.43e-06	4.17e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	5.42e-06	4.16e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AGT—coronary artery disease	5.4e-06	4.14e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTP1—coronary artery disease	5.36e-06	4.12e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—coronary artery disease	5.36e-06	4.11e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—coronary artery disease	5.36e-06	4.11e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—VCAN—coronary artery disease	5.35e-06	4.1e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—coronary artery disease	5.34e-06	4.1e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—coronary artery disease	5.34e-06	4.1e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	5.31e-06	4.08e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.31e-06	4.07e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	5.3e-06	4.07e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—coronary artery disease	5.29e-06	4.06e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—coronary artery disease	5.29e-06	4.06e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—coronary artery disease	5.29e-06	4.06e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL8—coronary artery disease	5.28e-06	4.05e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	5.28e-06	4.05e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KDR—coronary artery disease	5.25e-06	4.03e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KDR—coronary artery disease	5.23e-06	4.02e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	5.23e-06	4.01e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAT—coronary artery disease	5.22e-06	4e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	5.22e-06	4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	5.2e-06	3.99e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KDR—coronary artery disease	5.18e-06	3.98e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DCN—coronary artery disease	5.15e-06	3.95e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	5.15e-06	3.95e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	5.12e-06	3.93e-05	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	5.1e-06	3.92e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	5.1e-06	3.91e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOB—coronary artery disease	5.07e-06	3.89e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	5.06e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CASP3—coronary artery disease	5.06e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FN1—coronary artery disease	5.05e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—F2—coronary artery disease	5.05e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.05e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	5.05e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—F2—coronary artery disease	5.04e-06	3.87e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FN1—coronary artery disease	5.04e-06	3.87e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5.03e-06	3.86e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—coronary artery disease	5.02e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	5.02e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.01e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.01e-06	3.84e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—coronary artery disease	5e-06	3.84e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	4.99e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—F2—coronary artery disease	4.99e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FN1—coronary artery disease	4.99e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.98e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	4.98e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	4.97e-06	3.81e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	4.93e-06	3.78e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—coronary artery disease	4.93e-06	3.78e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCND1—coronary artery disease	4.92e-06	3.78e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAT—coronary artery disease	4.92e-06	3.77e-05	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	4.89e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LIPC—coronary artery disease	4.88e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HBA1—coronary artery disease	4.88e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.88e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.88e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOC3—coronary artery disease	4.85e-06	3.72e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CASP3—coronary artery disease	4.84e-06	3.72e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KIT—coronary artery disease	4.84e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—LPL—coronary artery disease	4.84e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LDLR—coronary artery disease	4.82e-06	3.7e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KIT—coronary artery disease	4.82e-06	3.7e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—coronary artery disease	4.81e-06	3.69e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—coronary artery disease	4.79e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—coronary artery disease	4.78e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KIT—coronary artery disease	4.78e-06	3.66e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOB—coronary artery disease	4.77e-06	3.66e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.77e-06	3.66e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.77e-06	3.66e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—coronary artery disease	4.72e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCND1—coronary artery disease	4.71e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCLC—coronary artery disease	4.71e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CETP—coronary artery disease	4.71e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SDC1—coronary artery disease	4.66e-06	3.57e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.64e-06	3.56e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	4.64e-06	3.56e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	4.63e-06	3.56e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	4.63e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—coronary artery disease	4.6e-06	3.53e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	4.6e-06	3.53e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CD36—coronary artery disease	4.6e-06	3.53e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—coronary artery disease	4.59e-06	3.52e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	4.59e-06	3.52e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	4.58e-06	3.52e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—coronary artery disease	4.58e-06	3.51e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—LPL—coronary artery disease	4.56e-06	3.5e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—coronary artery disease	4.55e-06	3.49e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	4.55e-06	3.49e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPP2CA—coronary artery disease	4.54e-06	3.48e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	4.51e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	4.49e-06	3.45e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	4.49e-06	3.45e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	4.48e-06	3.44e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	4.45e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—coronary artery disease	4.45e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	4.44e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	4.43e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	4.43e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	4.41e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	4.41e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.4e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.4e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	4.39e-06	3.37e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—coronary artery disease	4.38e-06	3.36e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	4.37e-06	3.36e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—coronary artery disease	4.35e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	4.35e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CD36—coronary artery disease	4.33e-06	3.32e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CTGF—coronary artery disease	4.3e-06	3.3e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	4.29e-06	3.29e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.28e-06	3.28e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.26e-06	3.27e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GOT2—coronary artery disease	4.26e-06	3.27e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.21e-06	3.23e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.21e-06	3.23e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	4.2e-06	3.22e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	4.19e-06	3.22e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.16e-06	3.19e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	4.15e-06	3.19e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AGT—coronary artery disease	4.14e-06	3.18e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	4.11e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.1e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.07e-06	3.12e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	4.06e-06	3.11e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—coronary artery disease	4.05e-06	3.11e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	4.02e-06	3.08e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	4.02e-06	3.08e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOA1—coronary artery disease	4.01e-06	3.08e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	4e-06	3.07e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	3.96e-06	3.04e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	3.94e-06	3.02e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.92e-06	3.01e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	3.9e-06	2.99e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AGT—coronary artery disease	3.9e-06	2.99e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	3.89e-06	2.99e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	3.86e-06	2.96e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	3.85e-06	2.96e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.82e-06	2.94e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—coronary artery disease	3.82e-06	2.93e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	3.81e-06	2.93e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.8e-06	2.91e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOA1—coronary artery disease	3.78e-06	2.9e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	3.78e-06	2.9e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	3.77e-06	2.89e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	3.7e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GGT1—coronary artery disease	3.68e-06	2.82e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GOT1—coronary artery disease	3.68e-06	2.82e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	3.56e-06	2.73e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	3.55e-06	2.72e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—coronary artery disease	3.53e-06	2.71e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	3.52e-06	2.7e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—coronary artery disease	3.48e-06	2.67e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	3.44e-06	2.64e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	3.43e-06	2.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	3.41e-06	2.62e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	3.4e-06	2.61e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	3.4e-06	2.61e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	3.39e-06	2.6e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	3.38e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	3.37e-06	2.58e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	3.35e-06	2.57e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	3.34e-06	2.57e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—coronary artery disease	3.33e-06	2.55e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.32e-06	2.55e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	3.31e-06	2.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.3e-06	2.54e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—coronary artery disease	3.28e-06	2.52e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	3.28e-06	2.51e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.27e-06	2.51e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.26e-06	2.5e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.22e-06	2.47e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAT—coronary artery disease	3.21e-06	2.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	3.18e-06	2.44e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—coronary artery disease	3.18e-06	2.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.12e-06	2.4e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOB—coronary artery disease	3.12e-06	2.39e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	3.11e-06	2.39e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.08e-06	2.37e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—coronary artery disease	3.04e-06	2.33e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.04e-06	2.33e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—coronary artery disease	2.99e-06	2.3e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LPL—coronary artery disease	2.98e-06	2.29e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—coronary artery disease	2.97e-06	2.28e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.91e-06	2.23e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.89e-06	2.22e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	2.88e-06	2.21e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.86e-06	2.2e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.86e-06	2.19e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—coronary artery disease	2.84e-06	2.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CD36—coronary artery disease	2.83e-06	2.17e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.8e-06	2.15e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—coronary artery disease	2.78e-06	2.13e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	2.74e-06	2.1e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CA—coronary artery disease	2.69e-06	2.07e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.68e-06	2.06e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	2.66e-06	2.04e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	2.65e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	2.62e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	2.62e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.62e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.6e-06	2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	2.6e-06	1.99e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.57e-06	1.97e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AGT—coronary artery disease	2.55e-06	1.96e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—coronary artery disease	2.5e-06	1.92e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.47e-06	1.89e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.26e-06	1.73e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	2.25e-06	1.73e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.23e-06	1.71e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKT1—coronary artery disease	2.2e-06	1.69e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—coronary artery disease	2.18e-06	1.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—coronary artery disease	2.15e-06	1.65e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—coronary artery disease	2e-06	1.54e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.99e-06	1.53e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.98e-06	1.52e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—coronary artery disease	1.96e-06	1.5e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.87e-06	1.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.85e-06	1.42e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.84e-06	1.41e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.82e-06	1.4e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.71e-06	1.31e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.71e-06	1.31e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.61e-06	1.24e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKT1—coronary artery disease	1.4e-06	1.07e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.32e-06	1.01e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.05e-06	8.08e-06	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKT1—coronary artery disease	8.6e-07	6.6e-06	CbGpPWpGaD
